Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive study reveals COVID-19 risks for autoimmune patients

NCT ID NCT04353609

First seen Jun 02, 2026 · Last updated Jun 20, 2026 · Updated 3 times

Summary

This study tracked over 13,000 patients with chronic inflammatory rheumatism, autoimmune, or auto-inflammatory diseases who had or were suspected to have COVID-19. Researchers wanted to find out how many developed severe COVID-19 that required intensive care or led to death. They also looked at risk factors like diabetes and obesity. The goal is to better understand and protect this vulnerable group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hôpital Huriez

    Lille, 59037, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors identify which patients with autoimmune diseases are at highest risk for severe COVID-19, leading to better monitoring and care.

What could go wrong

This is an observational study that only looks back at past data, so it cannot prove cause and effect. Results may not apply to all patient groups or future variants.

Conditions

The condition(s) this trial relates to.

autoimmune disease autoinflammatory syndrome COVID-19 rheumatic disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.